|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM301193908 |
003 |
DE-627 |
005 |
20231225104123.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2019 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.9b02175
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1003.xml
|
035 |
|
|
|a (DE-627)NLM301193908
|
035 |
|
|
|a (NLM)31510749
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Zhang, Shan
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Peripheral Antimicrobial Peptide Gomesin Induces Membrane Protrusion, Folding, and Laceration
|
264 |
|
1 |
|c 2019
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 21.09.2020
|
500 |
|
|
|a Date Revised 21.09.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Optical microscopy shows that the peripheral antimicrobial peptide (AMP) gomesin does not disrupt the bacterial membrane by forming stable transmembrane pores but induces lipid accumulation domains, which is followed by a sudden burst near the domains. The molecular action mechanisms of gomesin on vesicle and planar bilayer membranes are investigated in this work using coarse-grained molecular dynamics simulations. By comparing the membrane morphology and property changes induced by gomesin and the pore-forming AMP melittin, we determined that the amphiphilic shape of the AMPs is a key factor affecting the mechanism of cell death. The binding of wedge-shaped gomesin, with a small hydrophobic surface, onto the membrane induces protrusion and folding of the outer monolayer followed by sudden membrane lacerations at the axillae of the protuberances. Alternatively, cylinder-shaped melittins with comparable hydrophilic and hydrophobic surfaces destroy membranes by forming stable pores coexisting with exocytosis-like buddings and endocytosis-like invaginations. The multiple actions of AMPs on the bacterial membrane suggest diverse paradigms for designing molecular carriers for delivering drugs to the cell
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Anti-Bacterial Agents
|2 NLM
|
650 |
|
7 |
|a Antimicrobial Cationic Peptides
|2 NLM
|
650 |
|
7 |
|a Lipid Bilayers
|2 NLM
|
650 |
|
7 |
|a Liposomes
|2 NLM
|
650 |
|
7 |
|a gomesin
|2 NLM
|
650 |
|
7 |
|a Melitten
|2 NLM
|
650 |
|
7 |
|a 20449-79-0
|2 NLM
|
700 |
1 |
|
|a Fu, Lei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wan, Mingwei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Song, Junjie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gao, Lianghui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fang, Weihai
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 35(2019), 40 vom: 08. Okt., Seite 13233-13242
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:35
|g year:2019
|g number:40
|g day:08
|g month:10
|g pages:13233-13242
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.9b02175
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 35
|j 2019
|e 40
|b 08
|c 10
|h 13233-13242
|